- Home
- ASYS vs AVTE Comparison
ASYS vs AVTE Comparison
Compare ASYS & AVTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- AVTE
- Stock Information
- Founded
- ASYS 1981
- AVTE 2018
- Country
- ASYS United States
- AVTE United States
- Employees
- ASYS N/A
- AVTE N/A
- Industry
- ASYS Industrial Machinery/Components
- AVTE Biotechnology: Pharmaceutical Preparations
- Sector
- ASYS Technology
- AVTE Health Care
- Exchange
- ASYS Nasdaq
- AVTE Nasdaq
- Market Cap
- ASYS 81.3M
- AVTE 68.7M
- IPO Year
- ASYS N/A
- AVTE 2021
- Fundamental
- Price
- ASYS $5.27
- AVTE $2.37
- Analyst Decision
- ASYS
- AVTE Hold
- Analyst Count
- ASYS 0
- AVTE 7
- Target Price
- ASYS N/A
- AVTE $11.75
- AVG Volume (30 Days)
- ASYS 58.0K
- AVTE 140.8K
- Earning Date
- ASYS 02-05-2025
- AVTE 03-24-2025
- Dividend Yield
- ASYS N/A
- AVTE N/A
- EPS Growth
- ASYS N/A
- AVTE N/A
- EPS
- ASYS 0.08
- AVTE N/A
- Revenue
- ASYS $100,679,000.00
- AVTE N/A
- Revenue This Year
- ASYS $8.24
- AVTE N/A
- Revenue Next Year
- ASYS N/A
- AVTE N/A
- P/E Ratio
- ASYS $66.17
- AVTE N/A
- Revenue Growth
- ASYS N/A
- AVTE N/A
- 52 Week Low
- ASYS $4.60
- AVTE $1.25
- 52 Week High
- ASYS $6.96
- AVTE $32.42
- Technical
- Relative Strength Index (RSI)
- ASYS 58.96
- AVTE 37.24
- Support Level
- ASYS $5.34
- AVTE $2.35
- Resistance Level
- ASYS $5.87
- AVTE $2.49
- Average True Range (ATR)
- ASYS 0.36
- AVTE 0.10
- MACD
- ASYS 0.09
- AVTE -0.01
- Stochastic Oscillator
- ASYS 52.80
- AVTE 11.43
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About AVTE Aerovate Therapeutics Inc.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.